banner

News Details

Created with Pixso. Home Created with Pixso. News Created with Pixso.

Alpelisib Pivikto 150mg Sourcing: A B2B Procurement Checklist for PIK3CA-Mutated Breast Cancer

Alpelisib Pivikto 150mg Sourcing: A B2B Procurement Checklist for PIK3CA-Mutated Breast Cancer

2026-07-22

Overview

Procuring Alpelisib Pivikto for a hospital pharmacy or distributor means securing a PI3Kα inhibitor with verified PIK3CA-mutated breast cancer activity, not just a generic tablet. For B2B buyers, the real questions are batch consistency, lead time, and documentation rather than promotional claims. This guide covers the practical sourcing checklist that procurement teams need before committing to a supplier.

How It Works

Alpelisib selectively inhibits the p110α catalytic subunit of PI3K, the enzyme most often mutated in PIK3CA-driven tumors. By blocking this subunit, the drug interrupts a survival signal that would otherwise feed AKT and mTOR downstream. In hormone-receptor-positive, HER2-negative disease, cutting that signal re-sensitizes tumor cells to endocrine therapy. The 150 mg film-coated tablet is formulated for once-daily oral use alongside fulvestrant.

Indications

Alpelisib is indicated for postmenopausal women, and for men, with hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer whose tumors carry a PIK3CA mutation confirmed by testing. It is used after disease progression on or after an aromatase inhibitor, in combination with fulvestrant. Prescribers should confirm mutation status through an approved assay before initiating therapy.

Dosage & Administration

The recommended oral dose is 300 mg once daily, taken as two 150 mg tablets with food. Treatment continues until disease progression or unacceptable toxicity. If a dose is vomited or missed, do not take an extra tablet; resume the next scheduled dose. Dose reductions to 250 mg then 200 mg daily are defined for specific adverse events such as hyperglycemia or rash.

Storage & Sourcing

Alpelisib tablets should be stored at 20 to 25 °C with excursions permitted between 15 and 30 °C, protected from moisture. From a sourcing standpoint, buyers should request a Certificate of Analysis for every batch, confirm GMP and the originating manufacturer, and agree on a minimum order quantity and realistic lead time. Because this is a mutation-specific product, reconcile supplied quantities against validated PIK3CA testing demand to avoid overstock.

FAQ

Q: What is the typical minimum order quantity and lead time for Alpelisib Pivikto? A: Most B2B suppliers quote per carton of 28 tablets with lead times that depend on stock and customs; request a written quote and batch availability before ordering.

Q: Does Alpelisib require cold-chain transport? A: No dedicated frozen chain is needed; keep cartons below 30 °C and dry. Insist on intact, moisture-resistant secondary packaging for tropical transit.

Q: How should a buyer verify product authenticity? A: Ask for the batch-specific Certificate of Analysis, manufacturer authorization, and GMP evidence, then match the lot number on the carton before acceptance.

banner
News Details
Created with Pixso. Home Created with Pixso. News Created with Pixso.

Alpelisib Pivikto 150mg Sourcing: A B2B Procurement Checklist for PIK3CA-Mutated Breast Cancer

Alpelisib Pivikto 150mg Sourcing: A B2B Procurement Checklist for PIK3CA-Mutated Breast Cancer

Overview

Procuring Alpelisib Pivikto for a hospital pharmacy or distributor means securing a PI3Kα inhibitor with verified PIK3CA-mutated breast cancer activity, not just a generic tablet. For B2B buyers, the real questions are batch consistency, lead time, and documentation rather than promotional claims. This guide covers the practical sourcing checklist that procurement teams need before committing to a supplier.

How It Works

Alpelisib selectively inhibits the p110α catalytic subunit of PI3K, the enzyme most often mutated in PIK3CA-driven tumors. By blocking this subunit, the drug interrupts a survival signal that would otherwise feed AKT and mTOR downstream. In hormone-receptor-positive, HER2-negative disease, cutting that signal re-sensitizes tumor cells to endocrine therapy. The 150 mg film-coated tablet is formulated for once-daily oral use alongside fulvestrant.

Indications

Alpelisib is indicated for postmenopausal women, and for men, with hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer whose tumors carry a PIK3CA mutation confirmed by testing. It is used after disease progression on or after an aromatase inhibitor, in combination with fulvestrant. Prescribers should confirm mutation status through an approved assay before initiating therapy.

Dosage & Administration

The recommended oral dose is 300 mg once daily, taken as two 150 mg tablets with food. Treatment continues until disease progression or unacceptable toxicity. If a dose is vomited or missed, do not take an extra tablet; resume the next scheduled dose. Dose reductions to 250 mg then 200 mg daily are defined for specific adverse events such as hyperglycemia or rash.

Storage & Sourcing

Alpelisib tablets should be stored at 20 to 25 °C with excursions permitted between 15 and 30 °C, protected from moisture. From a sourcing standpoint, buyers should request a Certificate of Analysis for every batch, confirm GMP and the originating manufacturer, and agree on a minimum order quantity and realistic lead time. Because this is a mutation-specific product, reconcile supplied quantities against validated PIK3CA testing demand to avoid overstock.

FAQ

Q: What is the typical minimum order quantity and lead time for Alpelisib Pivikto? A: Most B2B suppliers quote per carton of 28 tablets with lead times that depend on stock and customs; request a written quote and batch availability before ordering.

Q: Does Alpelisib require cold-chain transport? A: No dedicated frozen chain is needed; keep cartons below 30 °C and dry. Insist on intact, moisture-resistant secondary packaging for tropical transit.

Q: How should a buyer verify product authenticity? A: Ask for the batch-specific Certificate of Analysis, manufacturer authorization, and GMP evidence, then match the lot number on the carton before acceptance.